The oncology adjuvants market is expanding due to rising cancer rates, personalized medicine demand, and advances in ...

WHAT: Invivyd, Inc. (Nasdaq: IVVD) is hosting the previously announced live webcast to present an overview of the company’s REVOLUTION clinical program, Invivyd’s development program for VYD2311, a ...

Observations on this point fail to carry conviction, however, because inadequate methods are used for ascertaining the facts. A method for the bioassay of diuretic agents in ambulant patients with ...

The main market opportunities in the esophageal cancer landscape focus on novel therapies in development across various stages, with over 80 companies involved. Key prospects lie in advanced drugs ...

ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings from its ongoing Phase 1 study of ...

The first needle-free adrenaline treatment launches in the UK, validating non-invasive delivery with real-world data comparable to injection effectiveness.

Challenges in respiratory vaccine development include immune response elicitation, personalized data, and alternative delivery methods like oral or intranasal routes to improve compliance. Federal ...

CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...

There are two ways a fondue night goes wrong: the oil smokes and stings your eyes, or the meat turns out grey and dry. Both ...

Often fuelled by a dire shortage of qualified nurses and the weak enforcement of health regulations, auxiliary nurses - ...